@article{ref1,
title="Psychopharmacological therapy of self-injurious behavior in mentally retarded individuals",
journal="Nervenarzt",
year="1999",
author="Hässler, F. and Fegert, Jörg Michael",
volume="70",
number="11",
pages="1025-1028",
abstract="Neurobiological research has implicated the dopamine and serotonin system in the pathogenesis of self-injurious behavior. The efficacy of antipsychotic drugs has been questioned. Opened and controlled investigations have shown risperidone is effective for reducing self-injurious behaviour in mentally retardation. We report about 3 mentally retarded patients which were given open-label risperidone for 12 weeks. They participated in a detailed assessment of behaviour symptoms at baseline and the repetitive behaviour was weekly rated with the disability assessment schedule (DAS). All three patients responded.<p /><p>Language: de</p>",
language="de",
issn="0028-2804",
doi="",
url="http://dx.doi.org/"
}